Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 949-956

  Angel, Peter ^a   Szabowski, Axel ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AP 1; Differentiation; Fibroblasts; Fos; Jun; Keratinocytes; Proliferation; Target genes; Tumourigenesis; Wound healing

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; KERATINOCYTE GROWTH FACTOR; PROTEIN C JUN; PROTEIN DERIVATIVE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CYTOARCHITECTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO DEVELOPMENT; EPIDERMIS; EPITHELIUM; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; FIBROBLAST; GENE FUNCTION; GENE TARGETING; HOMEOSTASIS; HUMAN; KERATINOCYTE; MESENCHYME; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SKIN; SKIN DISEASE;

ANIMALS; CELL COMMUNICATION; EPITHELIAL CELLS; FIBROBLASTS; HOMEOSTASIS; HUMANS; KERATINOCYTES; MESODERM; SKIN; SKIN DISEASES; TRANSCRIPTION FACTOR AP-1;

EID: 0036709021     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01158-9     Document Type: Article

References (56)

1. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
2. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
3. Wagner E.F. AP-1. Oncogene. 20:2001;2334-2497.
4. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumourigenesis. Oncogene. 20:2001;2401-2412.
5. Schorpp-Kistner M., Wang Z.Q., Angel P., Wagner E.F. JunB is essential for mammalian placentation. EMBO J. 18:1999;934-948.
6. Chiu R., Angel P., Karin M. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell. 59:1989;979-986.
7. Schütte J., Viallet J., Nau M., Segal S., Fedorko J., Minna J. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell. 59:1989;987-997.
8. Passegue E., Wagner E.F. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19:2000;2969-2979.
9. Passegue E., Jochum W., Schorpp-Kistner M., Mohle-Steinlein U., Wagner E.F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage. Cell. 104:2001;21-32.
10. Angel P., Szabowski A., Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene. 20:2001;2413-2423.
11. Luger T.A., Schwarz T. Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95:1990;100S-104S.
12. Schröder J.M. Cytokine networks in the skin. J. Invest. Dermatol. 105:1995;20S-24S.
13. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6896-6900.
14. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., Hofschneider P.H., Williams L.T. The function of KGF in morphogenesis of epithelium and re-epithelialisation of wounds. Science. 266:1994;819-822.
15. Maas-Szabowski N., Shimotoyodome A., Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J. Cell Sci. 112:1999;1843-1853.
16. Rheinwald J.G., Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells. Cell. 6:1975;331-343.
17. Bell E., Ehrlich H.P., Buttle D.J., Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 211:1981;1052-1054.
18. Mackenzie I.C., Fusenig N.E. Regeneration of organised epithelial structure. J. Invest. Dermatol. 81:1983;189S-194S.
19. Asselineau D., Prunieras M. Reconstruction of 'simplified' skin: control of fabrication. Br. J. Dermatol. 111:1984;219-222.
20. Smola H., Stark H.J., Thiekotter G., Mirancea N., Krieg T., Fusenig N.E. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp. Cell Res. 239:1998;399-410.
21. Garlick J.A., Taichman L.B. Fate of human keratinocytes during re-epithelialisation in an organotypic culture model. Lab. Invest. 70:1994;916-924.
22. Maas-Szabowski N., Stark H.J., Fusenig N.E. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 114:2000;1075-1084.
23. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103(2):2000;239-252.
24. Borden P., Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7:1997;159-178.
25. Maas-Szabowski N., Szabowski A., Stark H.J., Andrecht S., Kolbus A., Schorpp-Kistner M., Angel P., Fusenig N.E. Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J. Invest. Dermatol. 116:2001;816-820.
26. Szabowski A., Maas-Szabowski N., Andrecht S., Kolbus A., Schorpp-Kistner M., Fusenig N.E., Angel P. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell. 103:2000;745-755.
27. Fibbe W.E., Van Damme J., Billiau A., Duinkerken N., Lurvink E., Ralph P., Altrock B.W., Kaushansky K., Willemze R., Falkenburg J.H. Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood. 72:1988;860-866.
28. Kupper T.S., Lee F., Birchall N., Clark S., Dower S. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis. J. Clin. Invest. 82:1988;1787-1792.
29. Braunstein S., Kaplan G., Gottlieb A.B., Schwartz M., Walsh G., Abalos R.M., Fajardo T.T., Guido L.S., Krueger J.G. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J. Invest. Dermatol. 103:1994;601-604.
30. Eder M., Griffin J.D., Ernst T.J. The human granulocyte-macrophage colony-stimulating factor receptor is capable of initiating signal transduction in NIH3T3 cells. EMBO J. 12:1993;1647-1656.
31. Stein B., Baldwin A.S. Jr., Ballard D.W., Greene W.C., Angel P., Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
32. Baud V., Liu Z.G., Bennett B., Suzuki N., Xia Y., Karin M. Signaling by proinflammatory cytokines: oligomerisation of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13:1999;1297-1308.
33. Wang C, Fu M, D'Amico M, Albanese C, Zhou JN, Brownlee M, Lisanti MP, Chatterjee VK, Lazar MA, Pestell RG. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol Cell Biol 2001;21:3057-70.
34. Karin M., Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. U.S.A. 95:1998;9067-9069.
35. Israel A. The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10:2000;129-133.
36. Wajant H., Scheurich P. Tumour necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int. J. Biochem. Cell Biol. 33:2001;19-32.
37. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43:2000;801-811.
38. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:1999;6867-6874.
39. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2000;2123-2133.
40. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for egulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271:1996;3272-3278.
41. Jaakkola P., Maatta A., Jalkanen M. The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner. Oncogene. 17:1998;1279-1286.
42. Benbow U., Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15:1997;519-526.
43. Kähäri V.M., Saarialho-Kere U. Matrix metalloproteinases in skin. Exp. Dermatol. 6:1997;199-213.
44. Madlener M., Parks W.C., Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res. 242:1998;201-210.
45. Lund L.R., Romer J., Bugge T.H., Nielsen B.S., Frandsen T.L., Degen J.L., Stephens R.W., Dano K. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18:1999;4645-4656.
46. Bullard K.M., Lund L., Mudgett J.S., Mellin T.N., Hunt T.K., Murphy B., Ronan J., Werb Z., Banda M.J. Impaired wound contraction in stromelysin-1-deficient mice. Ann. Surg. 230:1999;260-265.
47. Lever WF. Histopathology of the Skin, 6th Ed. London: Pitman Medical Publishing, 1984.
48. Stefanidou M.P., Ioannidou D.J., Panayiotides J.G., Tosca A.D. Low molecular weight heparin: a novel alternative therapeutic approach for lichen planus. Br. J. Dermatol. 141:1999;1040-1045.
49. Saiag P., Coulomb B., Lebreton C., Bell E and Dubertret L. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science. 230:1985;669-672.
50. Philips N., Bashey R.I., Jimenez S.A. Increased alpha 1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of a negative regulatory sequence with AP-1 transcription factor. J. Biol. Chem. 270:1995;9313-9321.
51. Saito S., Nishimura H., Brumeanu T.D., Casares S., Stan A.C., Honjo T., Bona C.A. Characterisation of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice. Mol. Immunol. 36:1999;169-176.
52. Hatamochi A., Arakawa M., Mori K., Mori Y., Ueki H., Yoshioka H. Increased expression of type VI collagen genes in cutis laxa fibroblasts. J. Dermatol. Sci. 11:1996;97-103.
53. Teofoli P., Barduagni S., Ribuffo M., Campanella A., De Pita O., Puddu P. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J. Dermatol. Sci. 22:1999;31-37.
54. Werner S., Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol. 11:2001;143-146.
55. Frank S., Madlener M., Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271:1996;10188-10193.
56. Munz B., Smola H., Engelhardt F., Bleuel K., Brauchle M., Lein I., Evans L.W., Huylebroeck D., Balling R., Werner S. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18:1999;5205-5215.